New agents and approaches in the treatment of multiple myeloma

Clin Adv Hematol Oncol. 2003 Mar;1(3):151-2.
No abstract available

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Boronic Acids / therapeutic use
  • Bortezomib
  • Clinical Trials as Topic
  • Humans
  • Lenalidomide
  • Multiple Myeloma / drug therapy*
  • Pyrazines / therapeutic use
  • Thalidomide / analogs & derivatives
  • Thalidomide / therapeutic use
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Pyrazines
  • Thalidomide
  • Bortezomib
  • Lenalidomide